GNAQ and uveal melanoma: The important role of Gαq signalling in the development of uveal melanoma has been further supported by the identification of recurrent mutations in PLCB4 (p.D630, encoding phospholipase C β4) and CYSLTR2 (p.L129Q, encodinga Gαq-coupled receptor) [20, 21].